Phase II Trial of Oral Altretamine for Consolidation of Clinical Complete Remission in Women with Stage III Epithelial Ovarian Cancer: A Southwest Oncology Group Trial (SWOG-9326)

Authors:

Abstract
No abstract available

This publication has 29 references indexed in Scilit: